<div><b>References</b></div><div>1. Zhuo C, Ji F, Lin X, et al. Depression and recurrence of atrial
fibrillation after catheter ablation: a meta-analysis of cohort studies.
J Affect Disord 2020;271:27-32. DOI: 10.1016/j.jad.2020.03.118.</div><div>2. Packer DL, Mark DB, Robb RA, et al. Effect of Catheter Ablation vs
Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac
Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized
Clinical Trial. JAMA 2019;321(13):1261-1274. (In eng). DOI:
10.1001/jama.2019.0693.</div><div>3. Chew DS, Li Y, Cowper PA, et al. Cost-Effectiveness of Catheter
Ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: The
CABANA Randomized Clinical Trial. Circulation 2022;146(7):535-547. DOI:
10.1161/CIRCULATIONAHA.122.058575.</div><div>4. Bunch TJ, May HT, Bair TL, et al. Five-year outcomes of catheter
ablation in patients with atrial fibrillation and left ventricular
systolic dysfunction. J Cardiovasc Electrophysiol 2015;26(4):363-370.
DOI: 10.1111/jce.12602.</div><div>5. Bunch TJ, May HT, Bair TL, et al. The Impact of Age on 5-Year
Outcomes After Atrial Fibrillation Catheter Ablation. J Cardiovasc
Electrophysiol 2016;27(2):141-6. DOI: 10.1111/jce.12849.</div><div>6. Verma A, Jiang CY, Betts TR, et al. Approaches to catheter ablation
for persistent atrial fibrillation. N Engl J Med 2015;372(19):1812-22.
DOI: 10.1056/NEJMoa1408288.</div><div>7. Kirchhof P, Camm AJ, Goette A, et al. Early Rhythm-Control Therapy in
Patients with Atrial Fibrillation. N Engl J Med 2020;383(14):1305-1316.
(In eng). DOI: 10.1056/NEJMoa2019422.</div>